Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment
- Autores
- Campassi, María Luz; Gonzalez, María Cecilia; Masevicius, Fabio Daniel; Risso Vazquez, Alejandro; Moseinco, Miriam; Navarro, Noelia Cintia; Previgliano, Luciana; Rubatto, Nahuel Paolo; Benites, Martín Hernán; Estenssoro, Elisa; Dubin, Arnaldo
- Año de publicación
- 2014
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Objective: An augmented renal clearance has been described in some groups of critically ill patients, and it might induce sub-optimal concentrations of drugs eliminated by glomerular filtration, mainly antibiotics. Studies on its occurrence and determinants are lacking. Our goals were to determine the incidence and associated factors of augmented renal clearance and the efects on vancomycin concentrations and dosing in a series of intensive care unit patients. Methods: We prospectively studied 363 patients admitted during 1 year to a clinical-surgical intensive care unit. Patients with serum creatinine >1.3mg/dL were excluded. Creatinine clearance was calculated from a 24-hour urine collection. Patients were grouped according to the presence of augmented renal clearance (creatinine clearance >120mL/min/1.73m2), and possible risk factors were analyzed with bivariate and logistic regression analysis. In patients treated with vancomycin, dosage and plasma concentrations were registered. Results: Augmented renal clearance was present in 103 patients (28%); they were younger (48±15 versus 65±17 years, p>0.0001), had more frequent obstetric (16 versus 7%, p=0.0006) and trauma admissions (10 versus 3%, p=0.016) and fewer comorbidities. The only independent determinants for the development of augmented renal clearance were age (OR 0.95; p<0.0001; 95%CI 0.93-0.96) and absence of diabetes (OR 0.34; p=0.03; 95%CI 0.12-0.92). Twelve of the 46 patients who received vancomycin had augmented renal clearance and despite higher doses, had lower concentrations. Conclusions: In this cohort of critically ill patients, augmented renal clearance was a common finding. Age and absence of diabetes were the only independent determinants. Therefore, younger and previously healthy patients might require larger vancomycin dosing.
Facultad de Ciencias Médicas - Materia
-
Ciencias Médicas
Creatinine
Metabolic clearance rate
Sepsis/drug therapy
Vancomycin/pharmacokinetics
Vancomycin/therapeutic use - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by-nc-sa/4.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/85624
Ver los metadatos del registro completo
id |
SEDICI_4e7933b34575e1ff58c67ef7fdd3aed1 |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/85624 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatmentIncremento da depuração renal em pacientes gravemente enfermos: Incidência, fatores associados e efeitos no tratamento com vancomicinaCampassi, María LuzGonzalez, María CeciliaMasevicius, Fabio DanielRisso Vazquez, AlejandroMoseinco, MiriamNavarro, Noelia CintiaPrevigliano, LucianaRubatto, Nahuel PaoloBenites, Martín HernánEstenssoro, ElisaDubin, ArnaldoCiencias MédicasCreatinineMetabolic clearance rateSepsis/drug therapyVancomycin/pharmacokineticsVancomycin/therapeutic useObjective: An augmented renal clearance has been described in some groups of critically ill patients, and it might induce sub-optimal concentrations of drugs eliminated by glomerular filtration, mainly antibiotics. Studies on its occurrence and determinants are lacking. Our goals were to determine the incidence and associated factors of augmented renal clearance and the efects on vancomycin concentrations and dosing in a series of intensive care unit patients. Methods: We prospectively studied 363 patients admitted during 1 year to a clinical-surgical intensive care unit. Patients with serum creatinine >1.3mg/dL were excluded. Creatinine clearance was calculated from a 24-hour urine collection. Patients were grouped according to the presence of augmented renal clearance (creatinine clearance >120mL/min/1.73m2), and possible risk factors were analyzed with bivariate and logistic regression analysis. In patients treated with vancomycin, dosage and plasma concentrations were registered. Results: Augmented renal clearance was present in 103 patients (28%); they were younger (48±15 versus 65±17 years, p>0.0001), had more frequent obstetric (16 versus 7%, p=0.0006) and trauma admissions (10 versus 3%, p=0.016) and fewer comorbidities. The only independent determinants for the development of augmented renal clearance were age (OR 0.95; p<0.0001; 95%CI 0.93-0.96) and absence of diabetes (OR 0.34; p=0.03; 95%CI 0.12-0.92). Twelve of the 46 patients who received vancomycin had augmented renal clearance and despite higher doses, had lower concentrations. Conclusions: In this cohort of critically ill patients, augmented renal clearance was a common finding. Age and absence of diabetes were the only independent determinants. Therefore, younger and previously healthy patients might require larger vancomycin dosing.Facultad de Ciencias Médicas2014info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf13-20http://sedici.unlp.edu.ar/handle/10915/85624enginfo:eu-repo/semantics/altIdentifier/issn/0103-507Xinfo:eu-repo/semantics/altIdentifier/doi/10.5935/0103-507X.20140003info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by-nc-sa/4.0/Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:16:24Zoai:sedici.unlp.edu.ar:10915/85624Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:16:25.296SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment Incremento da depuração renal em pacientes gravemente enfermos: Incidência, fatores associados e efeitos no tratamento com vancomicina |
title |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
spellingShingle |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment Campassi, María Luz Ciencias Médicas Creatinine Metabolic clearance rate Sepsis/drug therapy Vancomycin/pharmacokinetics Vancomycin/therapeutic use |
title_short |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
title_full |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
title_fullStr |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
title_full_unstemmed |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
title_sort |
Augmented renal clearance in critically ill patients: Incidence, associated factors and effects on vancomycin treatment |
dc.creator.none.fl_str_mv |
Campassi, María Luz Gonzalez, María Cecilia Masevicius, Fabio Daniel Risso Vazquez, Alejandro Moseinco, Miriam Navarro, Noelia Cintia Previgliano, Luciana Rubatto, Nahuel Paolo Benites, Martín Hernán Estenssoro, Elisa Dubin, Arnaldo |
author |
Campassi, María Luz |
author_facet |
Campassi, María Luz Gonzalez, María Cecilia Masevicius, Fabio Daniel Risso Vazquez, Alejandro Moseinco, Miriam Navarro, Noelia Cintia Previgliano, Luciana Rubatto, Nahuel Paolo Benites, Martín Hernán Estenssoro, Elisa Dubin, Arnaldo |
author_role |
author |
author2 |
Gonzalez, María Cecilia Masevicius, Fabio Daniel Risso Vazquez, Alejandro Moseinco, Miriam Navarro, Noelia Cintia Previgliano, Luciana Rubatto, Nahuel Paolo Benites, Martín Hernán Estenssoro, Elisa Dubin, Arnaldo |
author2_role |
author author author author author author author author author author |
dc.subject.none.fl_str_mv |
Ciencias Médicas Creatinine Metabolic clearance rate Sepsis/drug therapy Vancomycin/pharmacokinetics Vancomycin/therapeutic use |
topic |
Ciencias Médicas Creatinine Metabolic clearance rate Sepsis/drug therapy Vancomycin/pharmacokinetics Vancomycin/therapeutic use |
dc.description.none.fl_txt_mv |
Objective: An augmented renal clearance has been described in some groups of critically ill patients, and it might induce sub-optimal concentrations of drugs eliminated by glomerular filtration, mainly antibiotics. Studies on its occurrence and determinants are lacking. Our goals were to determine the incidence and associated factors of augmented renal clearance and the efects on vancomycin concentrations and dosing in a series of intensive care unit patients. Methods: We prospectively studied 363 patients admitted during 1 year to a clinical-surgical intensive care unit. Patients with serum creatinine >1.3mg/dL were excluded. Creatinine clearance was calculated from a 24-hour urine collection. Patients were grouped according to the presence of augmented renal clearance (creatinine clearance >120mL/min/1.73m2), and possible risk factors were analyzed with bivariate and logistic regression analysis. In patients treated with vancomycin, dosage and plasma concentrations were registered. Results: Augmented renal clearance was present in 103 patients (28%); they were younger (48±15 versus 65±17 years, p>0.0001), had more frequent obstetric (16 versus 7%, p=0.0006) and trauma admissions (10 versus 3%, p=0.016) and fewer comorbidities. The only independent determinants for the development of augmented renal clearance were age (OR 0.95; p<0.0001; 95%CI 0.93-0.96) and absence of diabetes (OR 0.34; p=0.03; 95%CI 0.12-0.92). Twelve of the 46 patients who received vancomycin had augmented renal clearance and despite higher doses, had lower concentrations. Conclusions: In this cohort of critically ill patients, augmented renal clearance was a common finding. Age and absence of diabetes were the only independent determinants. Therefore, younger and previously healthy patients might require larger vancomycin dosing. Facultad de Ciencias Médicas |
description |
Objective: An augmented renal clearance has been described in some groups of critically ill patients, and it might induce sub-optimal concentrations of drugs eliminated by glomerular filtration, mainly antibiotics. Studies on its occurrence and determinants are lacking. Our goals were to determine the incidence and associated factors of augmented renal clearance and the efects on vancomycin concentrations and dosing in a series of intensive care unit patients. Methods: We prospectively studied 363 patients admitted during 1 year to a clinical-surgical intensive care unit. Patients with serum creatinine >1.3mg/dL were excluded. Creatinine clearance was calculated from a 24-hour urine collection. Patients were grouped according to the presence of augmented renal clearance (creatinine clearance >120mL/min/1.73m2), and possible risk factors were analyzed with bivariate and logistic regression analysis. In patients treated with vancomycin, dosage and plasma concentrations were registered. Results: Augmented renal clearance was present in 103 patients (28%); they were younger (48±15 versus 65±17 years, p>0.0001), had more frequent obstetric (16 versus 7%, p=0.0006) and trauma admissions (10 versus 3%, p=0.016) and fewer comorbidities. The only independent determinants for the development of augmented renal clearance were age (OR 0.95; p<0.0001; 95%CI 0.93-0.96) and absence of diabetes (OR 0.34; p=0.03; 95%CI 0.12-0.92). Twelve of the 46 patients who received vancomycin had augmented renal clearance and despite higher doses, had lower concentrations. Conclusions: In this cohort of critically ill patients, augmented renal clearance was a common finding. Age and absence of diabetes were the only independent determinants. Therefore, younger and previously healthy patients might require larger vancomycin dosing. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Articulo http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/85624 |
url |
http://sedici.unlp.edu.ar/handle/10915/85624 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/issn/0103-507X info:eu-repo/semantics/altIdentifier/doi/10.5935/0103-507X.20140003 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by-nc-sa/4.0/ Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) |
dc.format.none.fl_str_mv |
application/pdf 13-20 |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1844616036660281344 |
score |
13.070432 |